Author name: Kirsten Boone

Phenobarbital may be a viable option for treating alcohol withdrawal syndrome (AWS) as both monotherapy and in combination with benzodiazepines. Studies suggest that phenobarbital may be superior to benzodiazepines in terms of adverse outcomes such as ICU admissions. However, more research is needed to make definitive recommendations.